Literature DB >> 19748921

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.

M D de Kruif, M Limper, H R Hansen, J de Ruiter, C A Spek, E C M van Gorp, I J ten Berge, A T Rowshani, H ten Cate, E W Meesters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19748921     DOI： 10.1136/ard.2009.109405

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology.

Authors:  Przemyslaw Kotyla
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-10       Impact factor: 5.346

2.  Use of atorvastatin in systemic lupus erythematosus in children and adolescents.

Authors:  L E Schanberg; C Sandborg; H X Barnhart; S P Ardoin; E Yow; G W Evans; K L Mieszkalski; N T Ilowite; A Eberhard; L F Imundo; Y Kimura; E von Scheven; E Silverman; S L Bowyer; M Punaro; N G Singer; D D Sherry; D McCurdy; M Klein-Gitelman; C Wallace; R Silver; L Wagner-Weiner; G C Higgins; H I Brunner; L Jung; J B Soep; A M Reed; J Provenzale; S D Thompson
Journal:  Arthritis Rheum       Date:  2012-01

Review 3.  Dyslipidemia in systemic lupus erythematosus.

Authors:  Melinda Zsuzsanna Szabó; Peter Szodoray; Emese Kiss
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Management of cardiovascular complications in systemic lupus erythematosus.

Authors:  Carly Skamra; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

Review 5.  Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

6.  Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial.

Authors:  Alimohammad Fatemi; Mahdi Moosavi; Zahra Sayedbonakdar; Ziba Farajzadegan; Mehdi Kazemi; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2014-05-13       Impact factor: 2.980

7.  Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis.

Authors:  Yanice Mendez-Fernandez; Amy Major
Journal:  Arthritis Res Ther       Date:  2010-09-15       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.